Cargando…

Iron Deficiency and Blood Donation: Links, Risks and Management

The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantadakis, Elpis, Panagopoulou, Paraskevi, Kontekaki, Eftychia, Bezirgiannidou, Zoe, Martinis, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749410/
https://www.ncbi.nlm.nih.gov/pubmed/36531435
http://dx.doi.org/10.2147/JBM.S375945
_version_ 1784850036785414144
author Mantadakis, Elpis
Panagopoulou, Paraskevi
Kontekaki, Eftychia
Bezirgiannidou, Zoe
Martinis, Georges
author_facet Mantadakis, Elpis
Panagopoulou, Paraskevi
Kontekaki, Eftychia
Bezirgiannidou, Zoe
Martinis, Georges
author_sort Mantadakis, Elpis
collection PubMed
description The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no harm. Iron deficiency without anemia (IDWA) and iron deficiency anemia (IDA) are common consequences of regular blood donation, and this activity is the most important factor affecting iron status in regular blood donors. Awareness of blood donation as a primary cause of sideropenia is surprisingly low among physicians. Blood donation screening identifies potential donors with IDA but is frequently inadequate to detect IDWA. For the assessment of body iron stores, plasma or serum ferritin, transferrin saturation (TSAT) and soluble transferrin receptors (sTfR) concentrations are the most widely used biochemical markers, although the percentage of hypochromic mature erythrocytes and the hemoglobin content of reticulocytes are also useful. IDWA can be prevented by limiting the total volume of blood collected, by iron deficiency screening and deferral of sideropenic donors, by prolonging the interdonation intervals, and by iron supplementation between donations. IDWA tends to be more prevalent in younger people, females, and high-intensity donors. A potentially effective strategy to address sideropenia in blood donors is serum ferritin testing, but this may lead to a higher rate of deferral. Most regular blood donors cannot replenish their iron deficit by an iron-rich diet alone and will benefit from low-dose oral iron administration with various commercially available products post-donation, a well-tolerated strategy. However, valid concerns exist regarding the possibility of worsening the iron overload in donors with undiagnosed hemochromatosis or masking the symptoms of a clinically important gastrointestinal hemorrhage or other underlying medical condition. Finally, educational efforts should be intensified to improve the awareness of blood donation as a primary cause of iron deficiency among physicians of all specialties.
format Online
Article
Text
id pubmed-9749410
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97494102022-12-15 Iron Deficiency and Blood Donation: Links, Risks and Management Mantadakis, Elpis Panagopoulou, Paraskevi Kontekaki, Eftychia Bezirgiannidou, Zoe Martinis, Georges J Blood Med Review The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no harm. Iron deficiency without anemia (IDWA) and iron deficiency anemia (IDA) are common consequences of regular blood donation, and this activity is the most important factor affecting iron status in regular blood donors. Awareness of blood donation as a primary cause of sideropenia is surprisingly low among physicians. Blood donation screening identifies potential donors with IDA but is frequently inadequate to detect IDWA. For the assessment of body iron stores, plasma or serum ferritin, transferrin saturation (TSAT) and soluble transferrin receptors (sTfR) concentrations are the most widely used biochemical markers, although the percentage of hypochromic mature erythrocytes and the hemoglobin content of reticulocytes are also useful. IDWA can be prevented by limiting the total volume of blood collected, by iron deficiency screening and deferral of sideropenic donors, by prolonging the interdonation intervals, and by iron supplementation between donations. IDWA tends to be more prevalent in younger people, females, and high-intensity donors. A potentially effective strategy to address sideropenia in blood donors is serum ferritin testing, but this may lead to a higher rate of deferral. Most regular blood donors cannot replenish their iron deficit by an iron-rich diet alone and will benefit from low-dose oral iron administration with various commercially available products post-donation, a well-tolerated strategy. However, valid concerns exist regarding the possibility of worsening the iron overload in donors with undiagnosed hemochromatosis or masking the symptoms of a clinically important gastrointestinal hemorrhage or other underlying medical condition. Finally, educational efforts should be intensified to improve the awareness of blood donation as a primary cause of iron deficiency among physicians of all specialties. Dove 2022-12-10 /pmc/articles/PMC9749410/ /pubmed/36531435 http://dx.doi.org/10.2147/JBM.S375945 Text en © 2022 Mantadakis et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Mantadakis, Elpis
Panagopoulou, Paraskevi
Kontekaki, Eftychia
Bezirgiannidou, Zoe
Martinis, Georges
Iron Deficiency and Blood Donation: Links, Risks and Management
title Iron Deficiency and Blood Donation: Links, Risks and Management
title_full Iron Deficiency and Blood Donation: Links, Risks and Management
title_fullStr Iron Deficiency and Blood Donation: Links, Risks and Management
title_full_unstemmed Iron Deficiency and Blood Donation: Links, Risks and Management
title_short Iron Deficiency and Blood Donation: Links, Risks and Management
title_sort iron deficiency and blood donation: links, risks and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749410/
https://www.ncbi.nlm.nih.gov/pubmed/36531435
http://dx.doi.org/10.2147/JBM.S375945
work_keys_str_mv AT mantadakiselpis irondeficiencyandblooddonationlinksrisksandmanagement
AT panagopoulouparaskevi irondeficiencyandblooddonationlinksrisksandmanagement
AT kontekakieftychia irondeficiencyandblooddonationlinksrisksandmanagement
AT bezirgiannidouzoe irondeficiencyandblooddonationlinksrisksandmanagement
AT martinisgeorges irondeficiencyandblooddonationlinksrisksandmanagement